SMTL ID : 6q4e.1

CDK2 in complex with FragLite33

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.06 Å

Oligo State

monomer

Ligands

2 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)

DMS.1: 6 residues within 4Å: Chain A: M.9, E.10, N.11, F.12, T.80, Y.85 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:E.10, A:N.11, A:N.11 pi-Cation interactions: A:Y.85 DMS.2: 6 residues within 4Å: Chain A: L.227, G.228, T.229, D.231, R.253, Y.277 1 PLIP interactions: 1 interactions with chain A Salt bridges: A:D.231

1 x HH5: 6-iodanyl-7~{H}-purin-2-amine(Non-covalent)

HH5.3: 10 residues within 4Å: Chain A: I.18, A.39, K.41, V.72, F.88, E.89, F.90, L.91, L.142, A.152 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:K.41, A:K.41, A:L.91, A:L.91

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Wood, D.J. et al., FragLites-Minimal, Halogenated Fragments Displaying Pharmacophore Doublets. An Efficient Approach to Druggability Assessment and Hit Generation. J.Med.Chem. (2019)

Release Date

2019-03-20

Peptides

Cyclin-dependent kinase 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Cyclin-dependent kinase 2

Related Entries With Identical Sequence